What is Seaport Res Ptn’s Estimate for Innospec Q2 Earnings?

Innospec Inc. (NASDAQ:IOSP) – Research analysts at Seaport Res Ptn decreased their Q2 2025 earnings estimates for shares of Innospec in a research report issued on Monday, February 24th. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will earn $1.35 per share for the quarter, down from their previous forecast of $1.39. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec’s Q3 2025 earnings at $1.39 EPS, Q4 2025 earnings at $1.60 EPS, FY2025 earnings at $5.72 EPS, Q1 2026 earnings at $1.63 EPS, Q2 2026 earnings at $1.57 EPS, Q3 2026 earnings at $1.59 EPS, Q4 2026 earnings at $1.79 EPS and FY2026 earnings at $6.58 EPS.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.

Separately, StockNews.com cut shares of Innospec from a “buy” rating to a “hold” rating in a report on Wednesday.

Innospec Stock Down 0.8 %

Innospec stock opened at $103.57 on Wednesday. The stock has a market cap of $2.59 billion, a P/E ratio of 72.94 and a beta of 1.09. Innospec has a twelve month low of $99.49 and a twelve month high of $133.71. The company’s 50-day moving average price is $110.29 and its two-hundred day moving average price is $112.31.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Wasatch Advisors LP increased its stake in Innospec by 0.6% in the third quarter. Wasatch Advisors LP now owns 1,805,546 shares of the specialty chemicals company’s stock valued at $204,189,000 after acquiring an additional 11,231 shares during the last quarter. State Street Corp boosted its position in Innospec by 2.1% in the third quarter. State Street Corp now owns 996,281 shares of the specialty chemicals company’s stock valued at $112,669,000 after buying an additional 20,744 shares in the last quarter. Victory Capital Management Inc. boosted its position in Innospec by 1.6% in the fourth quarter. Victory Capital Management Inc. now owns 922,220 shares of the specialty chemicals company’s stock valued at $101,500,000 after buying an additional 14,188 shares in the last quarter. Royce & Associates LP boosted its position in Innospec by 9.3% in the third quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company’s stock valued at $94,468,000 after buying an additional 70,902 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Innospec by 2.2% in the fourth quarter. Geode Capital Management LLC now owns 692,071 shares of the specialty chemicals company’s stock valued at $76,184,000 after buying an additional 14,788 shares in the last quarter. 96.64% of the stock is owned by institutional investors.

Insider Transactions at Innospec

In related news, SVP Corbin Barnes sold 598 shares of Innospec stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $103.06, for a total value of $61,629.88. Following the transaction, the senior vice president now directly owns 8,051 shares of the company’s stock, valued at $829,736.06. This trade represents a 6.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Milton C. Blackmore sold 652 shares of Innospec stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $67,351.60. Following the completion of the transaction, the director now directly owns 8,376 shares in the company, valued at $865,240.80. This trade represents a 7.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,696 shares of company stock valued at $794,853. 1.52% of the stock is currently owned by company insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.